AFM
AGN

Andesa Financial Management’s Allergan plc AGN Stock Holding History

Andesa Financial Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,368
Closed -$200K – 152
2019
Q1 		$200K Buy
+1,368
New +$198K 0.1% 141

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Andesa Financial Management's AGN Position: Q2 2019 in Review

Andesa Financial Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,368 shares — an estimated $200K sold.

Andesa Financial Management first reported a position in AGN in Q1 2019 and held it in 1 quarter. The position peaked at $200K in Q1 2019. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Andesa Financial Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Andesa Financial Management sold 1,368 Allergan plc shares in Q2 2019, an estimated $200K.
  • Andesa Financial Management first reported a position in Allergan plc in Q1 2019 and held it in 1 quarter.
  • Andesa Financial Management's Allergan plc position peaked at $200K in Q1 2019.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Andesa Financial Management's 13F filing for Q2 2019, filed 30 Jul 2019.